• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病与 55 岁及以上患者的非酒精性脂肪性肝病独立相关:一项基于人群的研究结果。

Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.

机构信息

Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

J Am Acad Dermatol. 2014 Mar;70(3):517-24. doi: 10.1016/j.jaad.2013.10.044. Epub 2013 Dec 24.

DOI:10.1016/j.jaad.2013.10.044
PMID:24373781
Abstract

BACKGROUND

Recent case-control studies observed an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with psoriasis, which is relevant in selecting optimal psoriasis treatment.

OBJECTIVE

We sought to compare the prevalence of NAFLD in people with psoriasis and those without psoriasis.

METHODS

This large prospective population-based cohort study (part of the Rotterdam Study) enrolled elderly participants (>55 years). NAFLD was diagnosed as fatty liver on ultrasonography in the absence of other liver diseases. Participants with psoriasis were identified using a validated algorithm. Multivariable logistic regression model was used to assess whether psoriasis was associated with NAFLD after adjusting for demographic, lifestyle characteristics, and laboratory findings.

RESULTS

In total, 2292 participants were included (mean age 76.2 ± 6.0 years; 58.7% female; mean body mass index 27.4 ± 4.2kg/m(2)) of whom 118 (5.1%) had psoriasis. The prevalence of NAFLD was 46.2% in patients with psoriasis compared with 33.3% for the reference group without psoriasis (P = .005). Psoriasis was significantly associated with NAFLD; after adjustment for alcohol consumption, pack-years and smoking status, presence of metabolic syndrome, and alanine aminotransferase, psoriasis remained a significant predictor of NAFLD (adjusted odds ratio 1.7, 95% confidence interval 1.1-2.6).

LIMITATIONS

This was a cross-sectional study.

CONCLUSION

Elderly participants with psoriasis are 70% more likely to have NAFLD than those without psoriasis independent of common NAFLD risk factors.

摘要

背景

最近的病例对照研究观察到银屑病患者中非酒精性脂肪性肝病(NAFLD)的患病率增加,这与选择最佳银屑病治疗方法有关。

目的

我们旨在比较银屑病患者和非银屑病患者中 NAFLD 的患病率。

方法

这项大型前瞻性基于人群的队列研究(鹿特丹研究的一部分)纳入了老年参与者(>55 岁)。NAFLD 通过超声检查在无其他肝病的情况下诊断为脂肪肝。使用验证算法识别银屑病患者。多变量逻辑回归模型用于评估在调整人口统计学、生活方式特征和实验室发现后,银屑病是否与 NAFLD 相关。

结果

共纳入 2292 名参与者(平均年龄 76.2 ± 6.0 岁;58.7%为女性;平均体重指数 27.4 ± 4.2kg/m²),其中 118 名(5.1%)患有银屑病。与无银屑病的参考组(33.3%)相比,银屑病患者的 NAFLD 患病率为 46.2%(P =.005)。银屑病与 NAFLD 显著相关;在调整饮酒量、吸烟状况、代谢综合征和丙氨酸氨基转移酶后,银屑病仍然是 NAFLD 的显著预测因素(调整后的优势比 1.7,95%置信区间 1.1-2.6)。

局限性

这是一项横断面研究。

结论

独立于常见的 NAFLD 危险因素,老年银屑病患者发生 NAFLD 的可能性是非银屑病患者的 70%。

相似文献

1
Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.银屑病与 55 岁及以上患者的非酒精性脂肪性肝病独立相关:一项基于人群的研究结果。
J Am Acad Dermatol. 2014 Mar;70(3):517-24. doi: 10.1016/j.jaad.2013.10.044. Epub 2013 Dec 24.
2
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.转诊至代谢门诊的HIV感染患者中的非酒精性脂肪性肝病:患病率、特征及预测因素
Clin Infect Dis. 2008 Jul 15;47(2):250-7. doi: 10.1086/589294.
3
Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.非酒精性脂肪性肝病——老年患者中常见的良性表现。
Liver Int. 2004 Dec;24(6):588-94. doi: 10.1111/j.1478-3231.2004.0969.x.
4
The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.印度南部一项研究显示,银屑病患者中非酒精性脂肪性肝病的患病率增加。
Australas J Dermatol. 2012 Aug;53(3):190-7. doi: 10.1111/j.1440-0960.2012.00905.x. Epub 2012 Jun 6.
5
Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.非酒精性脂肪性肝病与年轻西班牙裔人群的胰岛素抵抗有关。
Prev Med. 2011 Feb;52(2):174-7. doi: 10.1016/j.ypmed.2010.11.021. Epub 2010 Dec 14.
6
Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used.代谢综合征和非酒精性脂肪性肝病在西班牙人群中的表现:所用诊断标准的影响。
Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1007-11. doi: 10.1097/MEG.0b013e328355b87f.
7
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.非酒精性脂肪性肝病的患病率及危险因素:狄俄尼索斯营养与肝脏研究
Hepatology. 2005 Jul;42(1):44-52. doi: 10.1002/hep.20734.
8
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.慢性斑块状银屑病患者非酒精性脂肪性肝病的患病率、特征及严重程度
J Hepatol. 2009 Oct;51(4):778-86. doi: 10.1016/j.jhep.2009.06.008. Epub 2009 Jun 26.
9
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.丙型肝炎患者的非酒精性脂肪性肝病与代谢综合征的特征相关。
Am J Gastroenterol. 2003 Sep;98(9):2064-71. doi: 10.1111/j.1572-0241.2003.07640.x.
10
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.代谢风险因素患者的胆石症与非酒精性脂肪性肝病标志物
Scand J Gastroenterol. 2012 Feb;47(2):197-203. doi: 10.3109/00365521.2011.643481. Epub 2011 Dec 19.

引用本文的文献

1
Serum Levels of Human Neutrophil Peptides 1-3 (HNP1-3) as Potential Biomarkers in Psoriasis and Associated Comorbidities.人中性粒细胞肽1-3(HNP1-3)血清水平作为银屑病及相关合并症的潜在生物标志物
Biomedicines. 2025 Jul 3;13(7):1635. doi: 10.3390/biomedicines13071635.
2
Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease?银屑病、代谢综合征与甲氨蝶呤:这种关联是否适用于脂肪性肝病中的一个新亚类?
World J Hepatol. 2025 Apr 27;17(4):102978. doi: 10.4254/wjh.v17.i4.102978.
3
Drug-induced liver injury. Part I: Classification, diagnosis and treatment.
药物性肝损伤。第一部分:分类、诊断与治疗。
Clin Exp Hepatol. 2025 Mar;11(1):25-33. doi: 10.5114/ceh.2025.148329. Epub 2025 Mar 25.
4
Nephrological, Pulmonary, and Dermatological Complications in the Context of MAFLD/NAFLD: A Narrative Review.MAFLD/NAFLD背景下的肾脏、肺部和皮肤并发症:一项叙述性综述
Metabolites. 2025 Apr 14;15(4):272. doi: 10.3390/metabo15040272.
5
Unveiling the impact of psoriasis on liver health: does methotrexate play a villainous role?揭示银屑病对肝脏健康的影响:甲氨蝶呤是否扮演了有害角色?
Arch Dermatol Res. 2024 Jun 28;316(7):437. doi: 10.1007/s00403-024-03193-9.
6
Non-alcoholic Fatty Liver Disease Among Iraqi Patients With Psoriasis: A Case-Control Study.伊拉克银屑病患者中的非酒精性脂肪性肝病:一项病例对照研究。
Cureus. 2024 Apr 2;16(4):e57487. doi: 10.7759/cureus.57487. eCollection 2024 Apr.
7
Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.成年银屑病患者中非酒精性脂肪性肝病的患病率及风险:一项系统评价、荟萃分析和试验序贯分析
Medicine (Baltimore). 2024 May 3;103(18):e38007. doi: 10.1097/MD.0000000000038007.
8
Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet-A Comprehensive Review.交叉途径:非酒精性脂肪性肝病与银屑病二重奏——综合综述
Int J Mol Sci. 2024 Feb 24;25(5):2660. doi: 10.3390/ijms25052660.
9
Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.慢性斑块状银屑病患者白细胞介素水平与非酒精性脂肪性肝病:一项分析性病例对照研究
Indian J Dermatol. 2023 Jul-Aug;68(4):377-384. doi: 10.4103/ijd.ijd_1015_22.
10
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.银屑病与非酒精性脂肪性肝病发病机制的研究进展。
Semin Arthritis Rheum. 2023 Apr;59:152165. doi: 10.1016/j.semarthrit.2023.152165. Epub 2023 Jan 18.